4
Changes in Ownership
INOVIO PHARMACEUTICALS, INC. Filed Acc 0001936799-26-000006
Chief Medical Officer gave up 2,693 shares (to pay taxes)
- Chief Medical Officer acquired 9,450 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sumner Michael John Chief Medical Officer | 2026-05-20 | Option exercise | +9,450 | 44,731 | D | ||
| Sumner Michael John Chief Medical Officer | 2026-05-20 | Shares withheld for taxes | −2,693 | $1.23 | $3,312 | 42,038 | D |
| Derivatives | |||||||
| Sumner Michael John Chief Medical Officer | 2026-05-20 | Option exercise · Restricted Stock Unit | −9,450 | 18,900 | D | ||
| Sumner Michael John Chief Medical Officer | 2026-05-20 | Grant or award · Common Stock Option | +46,876 | 46,876 | D | ||
| Sumner Michael John Chief Medical Officer | 2026-05-20 | Grant or award · Restricted Stock Unit | +37,684 | 37,684 | D | ||
Loading xslF345X06/wk-form4_1779393902.xml…